Fulvestrant Zentiva 250 mg/5 ml, Injektionslösung in einer Fertigspritze
7680682810017
CH-68281
Injektionslösung
Associated product:
FULVESTRANT Zentiva 250 mg/5ml 2 ser pré 5 ml
1 / 2
google
Article details
- Package size
- 2
- Selling units
- 2
- Measure
- Fertigspritze(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
fulvestrantum
|
250.0 MG | Substance | Wirkstoff (Principe actif) |
|
alcohol benzylicus
|
500.0 MG | Substance | HBESI |
|
benzylis benzoas
|
750.0 MG | Substance | HBESI |
|
ethanolum 96 per centum
|
500.0 MG | Substance | HBESI |
|
ricini oleum raffinatum
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 329.05
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/08/2021
Authorization holder
Helvepharm AG
8500 Frauenfeld
Authorization information
- Swissmedic authorization number
- 68281
- Drug name
- Fulvestrant Zentiva, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- L02BA03
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 24/05/2021
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.2.
- Domain
- Human medicine
Package details
- Description (FR)
- FULVESTRANT Zentiva 250 mg/5ml 2 ser pré 5 ml
- Description (DE)
- FULVESTRANT Zentiva 250 mg/5ml 2 Fertspr 5 ml
- Market launch
- 24/05/2021
- Narcotic (BTM)
- No
Original drug
Faslodex, Injektionslösung
GTIN: 7680567780121
CHF 379.80